Dec 17, 2024 8:00am EST Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19
Dec 05, 2024 8:00am EST Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply Schedule
Nov 04, 2024 8:00am EST bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
Oct 21, 2024 10:45am EDT bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement
Oct 18, 2024 12:45pm EDT bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement
Oct 16, 2024 8:00am EDT bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines
